{
  "id": "c815e7183345a774",
  "title": "The high stakes for Huntington\u2019s patients",
  "description": "This week on \"The Readout LOUD\": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high stakes for patients.",
  "content": "This week on \"The Readout LOUD\": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high stakes for patients.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/29/readout-loud-podcast-huntingtons-patients-uniqure-gene-therapy/?utm_campaign=rss",
  "published_at": "2026-01-29T21:26:45+00:00",
  "fetched_at": "2026-01-30T00:27:47.504790+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "gene therapy"
  ],
  "location": null,
  "raw_data": {
    "title": "The high stakes for Huntington\u2019s patients",
    "description": "This week on \"The Readout LOUD\": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high stakes for patients.",
    "url": "https://www.statnews.com/2026/01/29/readout-loud-podcast-huntingtons-patients-uniqure-gene-therapy/?utm_campaign=rss",
    "published": "2026-01-29T21:26:45+00:00",
    "source": "STAT"
  }
}